UCSF

Janel Long-Boyle, PharmD

Professor of Clinical Pharmacy
Phone: +1 415 640-1569
490 Illinois Street, Rm 33E
UCSF Box 0613
San Francisco, CA 94158
United States

What I do

I am a translational scientist with research interests that include pediatric cancer therapeutics, pharmacokinetics, pharmacodynamics, pharmacogenomics, and clinical trial design. The majority of my research is focused around the chemotherapeutic and immunosuppressive agents used in the conditioning regimens of pediatric hematopoietic cell transplantation (HCT). Specifically, I am interested in how patient specific covariates such as age, renal function, or genetic variants involved in drug metabolism or distribution may influence drug clearance in the pediatric HCT population.

Departmental research area

My research expertise

pharmacokinetics, pharmacodynamics, Pediatric Pharmacology, pediatric hematology, Oncology, bone marrow transplantation

Clinical expertise

hematology, Oncology, bone marrow transplantation

Professional background

Biography

Dr. Boyle is a translational scientist with research interests that include pediatric cancer therapeutics, pharmacokinetics, pharmacodynamics, pharmacogenomics, and clinical trial design. The majority of her research resides within the complex setting of hematopoietic cell transplantation (HCT) and is focused around chemotherapeutic and immunosuppressive agents used in the preparative regimens of pediatric HCT. Specifically, Dr. Boyle studies how covariates such as age, renal function, or genetic variants involved in drug metabolism or distribution may influence drug clearance in the pediatric HCT population.

Research keywords

  • Oncology
  • Pharmacokinetics-Pharmacodynamics
  • Hematopoietic Cell Transplantation
  • Hematology
  • Pediatric Pharmacology
  • Mycophenolic Acid
  • Chimerism
  • Tandem Mass Spectrometry
  • Adenine Nucleotides
  • Arabinonucleosides
  • Hematopoietic Stem Cell Transplantation
  • Immunosuppressive Agents
  • Patient-Specific Modeling
  • Metabolic Diseases
  • Transplantation Conditioning
  • Busulfan
  • Biological Models
  • Melphalan
  • Vidarabine
  • Antineoplastic Agents, Alkylating